Dermapharm Holding SE (ETR:DMP)
Germany · Delayed Price · Currency is EUR 38.30
-0.50 (-1.29%)
Sep 10, 2026, 5:35 PM CET
Dermapharm Holding SE Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 195.56 | 203.41 | 121.31 | 158.72 | 151.02 | 161.41 |
Short-Term Investments | - | 1.06 | 0.59 | 0.82 | 1.48 | 1.76 |
Cash & Short-Term Investments | 195.56 | 204.46 | 121.9 | 159.54 | 152.5 | 163.18 |
Cash Growth | 20.21% | 67.74% | -23.60% | 4.62% | -6.54% | 32.85% |
Accounts Receivable | 136.69 | 110.66 | 102.18 | 95.41 | 96.72 | 72.52 |
Other Receivables | 2.3 | 10.78 | 11.25 | 40.39 | 8.41 | 14.29 |
Receivables | 138.99 | 121.44 | 113.43 | 135.8 | 105.13 | 86.81 |
Inventory | 371.02 | 328.71 | 343.38 | 320.76 | 255.72 | 243.6 |
Prepaid Expenses | - | 41.91 | 7.6 | 7.94 | 7 | 13.19 |
Other Current Assets | 57.94 | 6.4 | 7.19 | 6.45 | 13.6 | 12.45 |
Total Current Assets | 763.52 | 702.93 | 593.5 | 630.5 | 533.95 | 519.22 |
Property, Plant & Equipment | 331.93 | 318.54 | 315.03 | 330.77 | 225.67 | 222.29 |
Long-Term Investments | 30.88 | 33.67 | 21.87 | 25.06 | 36.57 | 105.62 |
Goodwill | 587.12 | 587.06 | 576.38 | 578.52 | 271.32 | 264.73 |
Other Intangible Assets | 491.87 | 379.09 | 406.14 | 441.61 | 212.12 | 217.13 |
Long-Term Deferred Charges | - | 101.35 | 106.18 | 103.25 | 92.92 | 77.72 |
Other Long-Term Assets | 37.02 | 0.92 | 0.94 | 0.97 | 0.28 | 0.27 |
Total Assets | 2,242 | 2,187 | 2,080 | 2,161 | 1,413 | 1,407 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 106.29 | 96.26 | 94.79 | 86.64 | 56.1 | 52.1 |
Accrued Expenses | - | 65.38 | 67.69 | 94.35 | 54.51 | 45.17 |
Short-Term Debt | 0.03 | 0.02 | 0.04 | 0.01 | 0 | - |
Current Portion of Long-Term Debt | 132.81 | 128.14 | 86.04 | 111.43 | 1.87 | 2.38 |
Current Portion of Leases | 6.35 | 6.86 | 5.12 | 5 | 3.02 | 3.2 |
Current Income Taxes Payable | 28.69 | 28.98 | 58.83 | 81.82 | 96.35 | 48.8 |
Current Unearned Revenue | - | 1.71 | 1.5 | 1.43 | 0.56 | 0.62 |
Other Current Liabilities | 171.74 | 15.58 | 12.91 | 13.82 | 5.38 | 3.35 |
Total Current Liabilities | 445.9 | 342.93 | 326.92 | 394.49 | 217.79 | 155.61 |
Long-Term Debt | 1,013 | 904.09 | 886.71 | 963.89 | 501.84 | 565.71 |
Long-Term Leases | 17.21 | 18.82 | 12.35 | 13.25 | 9.72 | 9.01 |
Long-Term Unearned Revenue | - | 11.06 | 11.34 | 11.69 | 9.2 | 9.46 |
Pension & Post-Retirement Benefits | 111.67 | 111.08 | 119.63 | 117.22 | 89.28 | 128.88 |
Long-Term Deferred Tax Liabilities | 110.03 | 105.07 | 111.7 | 112.39 | 50.52 | 36.06 |
Other Long-Term Liabilities | 11.94 | 3 | 3.08 | 2.71 | 1.99 | 2.41 |
Total Liabilities | 1,709 | 1,496 | 1,472 | 1,616 | 880.34 | 907.14 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 49.54 | 53.84 | 53.84 | 53.84 | 53.84 | 53.84 |
Retained Earnings | 372.22 | 515.91 | 433.19 | 367.22 | 355.36 | 337.95 |
Comprehensive Income & Other | 114.95 | 124.62 | 117.39 | 118.14 | 122.4 | 105.52 |
Total Common Equity | 536.71 | 694.38 | 604.42 | 539.21 | 531.59 | 497.32 |
Minority Interest | -3.75 | -3.61 | 3.87 | 5.84 | 0.9 | 2.52 |
Shareholders' Equity | 532.96 | 690.77 | 608.3 | 545.05 | 532.49 | 499.83 |
Total Liabilities & Equity | 2,242 | 2,187 | 2,080 | 2,161 | 1,413 | 1,407 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,169 | 1,058 | 990.26 | 1,094 | 516.45 | 580.3 |
Net Cash (Debt) | -973.45 | -853.46 | -868.36 | -934.03 | -363.95 | -417.13 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -18.41 | -15.85 | -16.13 | -17.35 | -6.76 | -7.75 |
Filing Date Shares Outstanding | 49.41 | 53.84 | 53.84 | 53.84 | 53.84 | 53.84 |
Total Common Shares Outstanding | 49.41 | 53.84 | 53.84 | 53.84 | 53.84 | 53.84 |
Working Capital | 317.61 | 360 | 266.58 | 236.01 | 316.16 | 363.61 |
Book Value Per Share | 10.86 | 12.90 | 11.23 | 10.01 | 9.87 | 9.24 |
Tangible Book Value | -542.28 | -271.77 | -378.1 | -480.92 | 48.15 | 15.46 |
Tangible Book Value Per Share | -10.97 | -5.05 | -7.02 | -8.93 | 0.89 | 0.29 |
Land | - | 258.71 | 247.87 | 252.54 | 171.75 | 163.41 |
Machinery | - | 279.01 | 252.92 | 234.8 | 178.45 | 163.77 |